|
|
| home about us advertise with us downloads links privacy contact us site map copyright policy |
| ||
IBS.pubThe Rome II diagnostic criteria are the current defining standard for IBS. There must have been at least 12 weeks in the last 12 months with abdominal discom-fort or pain that has two out of three of these features: 1. Relieved with defecation 70 to 90% of people with IBS have a mood disorder, anxiety or depression. Most also suffer from excessive fatigue or tiredness. 2. Onset associated with a change in frequency of stool; and/or 3. Onset associated with a change in form (appearance) of stool. 1. Abnormal stool frequency, de-fined as greater than 3 bowel movements per day and less than 3 bowel movements per week 2. 6. There is evidence from gut wall biopsies that the activity of some gut bacteria, embedded in an im-paired Gut wall, drives Irritable Bowel Syndrome and Inflamma-tory Bowel disease.Anderson%20Complete%20List%20of%20Entries[1]_5202FM-Anderson-Vol I 12/16/03 6:44 PM Page vii List of Entries Chronic Fatigue Syndrome: Fibromyalgia Syndrome: Fibromyalgia Syndrome: General Adaptation Syndrome Irritable Bowel Syndrome: Irritable Bowel Syndrome: Metabolic Syndrome and Stress disturbance of normal bowel function. Normally, gentle, rhythmic contrac-tions of the bowel walls push the fecal material toward the rectum; however with IBS these contractions are irregular, causing painful constipation and diarrhea. During IBS, the bowel muscle spasms and the build up of gas and fecal material in the colon cause pain to develop in the lower left side of the abdomen. Although IBS may be very painful and cause great discomfort, it does not damage the bowel or cause any other disease. IBS is a functional disorder, meaning that the bowel doesn't work the way it should because of poor nerve and muscle function. Some trig-gers that may cause the bowel to overact include: Gastroenteritis is an infection or irritation of the digestive tract (stomach and intestines) that may produce symptoms of nausea, vomiting, cramping, or diarrhea. -Foods that irritate the lining of the stomach -Not ignoring the urge to have a bowel movement Diarrhea is a condition British Medical JournalThe irritable bowel syn-drome, functional abdominal bloating, functional constipation, and functional diarrhea are distinguished by symptom-based diagnostic criteria. Keywords: functional bowel disorder; functional constipation; functional diarrhea; irritable bowel syndrome; functional abdominal pain; functional abdominal bloating; Rome II Abbreviations used in this paper : FBD, functional bowel disorder; IBS, irritable bowel syndrome; FAPS, functional abdominal pain syndrome. C1. Irritable bowel syndrome IBS comprises a group of functional bowel dis-orders in which abdominal discomfort or pain is associated with defecation or a change in bowel habit, and with features of disordered defecation. C5. UnspeciŽed functional bowel disorder An unspeciŽed functional bowel disorder is deŽned as functional bowel symptoms that do not meet criteria for the previously deŽned categories. of irritable bowel syndrome supported by factor analysis of symptoms in two communityRecentDevelopments2003Signature (required to process registration charged to credit card) Advance payment of fee is necessary to guarantee space. For your convenience, payment may be made by check or by credit card (VISA or MasterCard). Registrations charged to credit card may be faxed. Checks should be made payable to Office of CME. FIBROMYALGIA: The prevalence, nature, personal and societal impact of fibromyalgia and related chronic pain syndromes; A clinical approach in the diagnosis and differential diagnosis; Available pharmacological treatments and non-pharmacological management strategies. DYSLIPIDEMIA, DIABETES, METABOLIC SYNDROME: The clinical and laboratory manifes-tations of the dyslipidemias including the metabolic syndrome; Primary and secondary dyslipidemia; The LDL cholesterol goals and cut points for therapeutic lifestyle changes (TLC) and drug therapy in different risk categories. INFLAMMATORY BOWEL DISEASE: General principles of medical management; Managementhp_mar99_irbowlsynColonoscopy with biopsies Upper endoscopy with small bowel biopsies Transit test to evaluate small bowel and colon motility Abdominal pain Plain abdominal radiography Pelvic examination in women Trial of amitryptiline Small and large bowel barium series Gastrointestinal manometry, endoscopy, right upper quadrant Maxton DG, Morris J, Whorwell PJ: Selective 5- hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia? 39. Prior A, Read NW: Reduction in rectal sensitivity and postprandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome. 41. Dapoigny M, Abitbol JL, Fraitag B: Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. Wood JD: Efficacy of leuprolide in treatment of the irri-table bowel syndrome. Cann PA, Read NW, Holdsworth CD: Oral domperi-done: double blind comparison with placebo in irritable bowel syndrome. Van Outryve M, Milo R,mcq2193MCQ 2193 To give your patients the maximum benefit of your expertise, you need to review and continually update your knowledge. The Pharmacy Update modular course has been devised to provide you with an effective and enjoyable way to do this. You can test your increased understanding of topics covered in March's Pharmacy Update by answering the questions below. Those pharmacists who wish to register their answers may phone our telephone marking service on 08705 441188 (see overleaf for details). Asthma (Part 2 - management) (module 1193) - March 3 Irritable bowel syndrome (module 1194) - March 17 Drugs and the elderly (module 1195) - March 17 Correctly answering 80 per cent of all questions is sufficient to achieve three hours' continuing education credit. A) Irritable bowel syndrome is the second most common cause of absenteeism from work and school True 1 False 2 B) Symptoms of irritable bowel syndrome frequently include epigastric pain True 1 False 2 C) ReliefHDL2003_02reportIn my days as a General Practitioner I was often made aware of the considerable difficulties experienced by people presenting then with what now we would recognise as Chronic Fatigue Syndrome or ME. In the years that have passed, the advent of effective and available services has been delayed by disagreement on fundamental issues about the causation, and thus, by implication, the appropriate treatment of the disorder. Were we to wait for clarity about the origin of the disorder before deciding on a way forward, many would continue to experience those difficulties I remember so well from my former patients. Of course there was the positive implication that this indeed was a disorder suitable and appropriate to a health service approach. Health Department officials from Edinburgh attended meetings of the English group with the intention of using its conclusions as a guide to Scottish service development. Such services provided by individual clinicians and other newCCP and IBSThe same principles apply to your bowels. Unless you drink at least 8-10 glasses of water per day, the increased fibre intake may "cake" in the bowels and worsen constipation. Bowel related pain could take as long as 3-6 months to settle following a change of dietary habits. the most common and frequently underdiagnosed condition is Irritable Bowel Syndrome (IBS) or otherwise commonly known as constipation. It is the commonest bowel disorder affecting 10% of the population. Symptoms and severity of symptoms will vary greatly from person to person: Lower abdominal pain - continuous or colicky Bloating which can be worse towards the end of the day Diarrhoea or constipation although bowel motions may be normal a feeling of incomplete emptying of the bowel a dull throbbing ache lasting for a few hours after intercourse you may have pain in the shaded areas shown in the diagram you may be able to feel tender lumps in these shaded areas Why was I referred to a Gynaecologist?informed plus #6114This document contains information that is supplementary to an article that appeared in the informed newsletter, Vol 6 No 1, Dec. 1999 Recognition An otherwise well patient presents with variable combination of chronic or recurrent abdominal pain, altered bowel habit (constipation, diarrhea or both) and bloating. Make a positive diagnosis Use Manning criteria: abdominal pain plus 2 or more of the following: Pain relieved by defecation* Pain associated with looser stools* Pain associated with more frequent stools* (* most responsible diagnosis, more useful in women) Focused physical examination important (including rectal) Abdominal tenderness or palpable colon may be present in irritable bowel syndrome (IBS) Uncertainty about diagnosis or excessive patient concern that diagnosis is incorrect. Resistant symptoms that impair patient's ability to function. Gut and brain interact to alter motility (muscle contractions) and/or increase bowel sensation A chronic, relapsing butTummyCareCatalog.inddh is recipe is not just safe for IBS, it's sinfully rich with deep dark chocolate, ridiculously easy to make, and completely delicious. Makes 12 Servings Preheat oven to 325F Spray a 10" bundt pan or 9" x 5" loaf pan with cooking oil and set aside. Clinically proven prebiotic e ect Alleviates diarrhea and constipation Regulates bowel motility No colors or fl avors No insoluble fi ber No citric acid Non-thickening Add to any Studies have shown that soluble fi ber, as part of the diet, regulates bowel motility (alleviating both diarrhea AND constipation), and relieves abdominal pain from IBS. Acacia's prebiotic e) ect stimulates the growth of healthy gut fl ora, which in turn reduces bloating, gas, and bowel irregularities from IBS. Peppermint, ginger, and fennel are digestive aids that, as part of the diet, help relieve IBS symptoms, including abdominal pain, bowel motility, and bloating. In addition, the Hot Packs can provide unparalleled relaxation and thus helpBioadhesive Films for Topical and Transmucosal Drug DeliveryBioadhesive Films for Topical and Transmucosal Drug Delivery James W. McGinity, Ph.D., and Robert O. (Bill) Williams III, Ph.D. College of Pharmacy The Challenge: Drug delivery through the skin and mucosal membrane in the oral cavity: No water or solvents Simple process - novel composition Suitable for a wide variety of drugs Removable and non-irritating Irritable Bowel SyndromePA270.02_SynbioticUC.inddResearchers from the University of Dundee have developed a novel synbiotic formulation that promotes the growth of beneficial bacteria. A pilot trial has demonstrated the potential of the synbiotic for treatment of ulcerative colitis. This treatment provides effective therapy by promoting the body's own defence system and reducing inflammation in the bowel of patients. Background Ulcerative colitis (UC) is a form of inflammatory bowel disease affecting half a million people in the USA and over 120,000 in the UK. Existing treatment for UC depends on the extent and severity of the condition, but can involve a progression from initial treatment with anti-inflammatories through immuno suppressors and then steroid therapies . Patients may require periods of hospitalisation in severe cases. Mild forms of inflammatory bowel dis-ease and Irritable Bowel Syndrome would also benefit from synbiotic therapy, open-ing up a potentially huge global market. - Further clinical trialsCYBILL SHEPHERD LEADS AMAZING WOMEN CAMPAIGNA national survey of 1,000 adults reveals more than 13 percent of them suffered from symptoms of IBS, but less than one out of five of them had actually been diagnosed with the condition, according to the International Foundation for Functional Gastrointestinal Disorders (IFFGD). Among respondents who experienced distress similar to IBS, 85 percent called their symptoms bothersome and close to 30 percent said the symptoms interfered with their lifestyle at least once a week. Only 66 percent of those questioned had heard of IBS and only 17 percent had an understanding of the condition. The IFFGD recommends individuals who have significant bowel distress and pain contact their health care professional to gain an accurate diagnosis and begin treatment to reduce its symptoms. It's important to also record the time and description of distressing bowel events or related pain and discomfort. The National Institute of Diabetes and Digestive and Kidney Disease recommends consultingThis research reveals significant opportunities to better manage IBS, a chronic health condition affecting up to 30 million Americans. Pharmaceutical companies, health insurers, care managers, and othe r healthcare players can realize substantial benefits by taking action to enhance IBS care and improve patient satisfaction. Please contact Melissa Krauth at (978) 475-0428 for additional information about the IBSVoice study or research with DrugVoice's disease-focused panels. Many Patients Severely Impacted by IBS, Resulting in High Healthcare Costs IBS is a chronic health condition in which patients experience symptoms of frequent diarrhea and/or constipation, accompanied by abdominal pain. It affects 10-15% of the population, with most remaining undiagnosed. Medic al costs associated with IBS are significant, and are likely to rise as outreach eff orts by patient advocacy groups and pharmaceutical companies increase diagnosis. About the Irritable Bowel Syndrome (IBS) Self pelvicpainThis pain can have many causes which may involve the reproductive organs and sometimes the nearby u r i n a ry tract, bowel, or other abdominal structures. Prostaglandins can also affect other body tissues and are responsible for the mild nausea and loose bowel movements which some women experience during the menstrual period. A l t h o u g h small fibroids may not cause any symptoms, large fibroids can place pres-sure on adjacent structures such as the bladder or bowel. Bowel problems can cause pain which may affect the pelvis and abdomen. If bowel or urinary tract problems are discovered, specific causes can be treated appropriately. Bands of fibrous scar tissue that may bind the pelvic organs and/or loops of bowel together. Test using a radio opaque medium and x-ray to identify any blockages in the lower bowel or intestinal tract using dye placed through the rectum. Passage of a lighted scope through the rectum into the colon to visualize the lining of the large bowel1 | 2 | 3
| 4 | 5 | 6
| 7 | 8 | 9
| 10 | 11 | 12
| 14 | 15 | | ||
